“…Their derivatives have shown promise as antifungal agents, primarily by impeding the synthesis of ergosterol, a key constituent of the fungal cell membrane [12,13].This inhibition is achieved through the suppression of the fungal cytochrome P450 enzyme, ultimately resulting in fungal apoptosis [14]. Moreover, azole based compounds possess various biological activity such as, anticonvulsants, antidepressants, antioxidants, antiinflammatory agents, antibiotics, anti-fungal agents, antiviral agents, and so on [15]. Triazole compounds, including fluconazole, itraconazole, voriconazole [16], posaconazole, albaconazole, efinaconazole, ravuconazole, and isavuconazole, have garnered significant interest within the field of azole drugs [17].This heightened attention can be attributed to their wider range of effectiveness, favorable pharmacokinetic properties, selectivity, and satisfactory safety profile [18].…”